Terumo Heart Inc. Names Tom Gould and Mark Bullivant to Senior Management Positions in Left Ventricular Assist Device Market

ANN ARBOR, Mich., Aug. 5 /PRNewswire/ -- Terumo Heart, Inc., a wholly owned subsidiary of Terumo Corporation, today announced that it has named Thomas (Tom) B. Gould as Vice President, Clinical Affairs and Mark A. Bullivant, as Director, International Sales.

Bullivant joins Terumo from St Jude Medical, where he held a number of management positions within the International Cardiac Surgical business, and more recently from Ulthera Inc. as International Zone Director, with responsibilities for the Middle East, Far East and Latin America. Bullivant will focus on the development of Terumo's International DuraHeart business.

The DuraHeart LVAS is the first, third-generation rotary pump designed for long-term patient support that incorporates a centrifugal flow rotary pump with an active magnetically levitated impeller featuring three position sensors and magnetic coils that optimize blood flow, while minimizing device wear and tear. The ongoing DuraHeart Pivotal U.S. Trial for Bridge-to-Transplant is evaluating the safety and efficacy of the device in helping to sustain patients awaiting heart transplant who are at risk of death due to end-stage left ventricular failure. The DuraHeart LVAS carries a CE Mark and is currently available for sale in European countries. Additionally, the company has completed clinical trial enrollment for this device in Japan.

About Terumo Heart, Inc.

Terumo Heart, Inc. is a U.S. subsidiary of Terumo Corporation with headquarters and manufacturing facilities in Ann Arbor, Michigan. The company's focus is the innovation and introduction of products to improve the quality of healthcare for heart failure patients. Terumo Corporation, located in Tokyo, Japan, is a leading developer, manufacturer and global marketer of a wide array of medical products. DuraHeart is limited to investigational use only in the United States, and is CE marked in Europe. For more information visit www.terumoheart.com.

Terumo Heart, Inc.